Alzheimer’s-Program to Accelerate Clinical Trials



PRECLINICAL DRUG DISOCVERY RFP: The Alzheimer’s Drug Discovery Foundation (ADDF) seeks to fill the critical translational funding gap between basic research and later stage drug development by funding promising preclinical drug discovery and biomarker development programs relevant to Alzheimer’s disease, other dementias and cognitive aging. See full RFP here.

PACT RFP: The ADDF has created the Program to Accelerate Clinical Trials (PACT) to increase the number of innovative drugs tested in humans at the crucial proof of concept stage for Alzheimer’s disease. This program will fund biomarker-based, proof-of-concept pilot clinical trials for Alzheimer’s. 2014 deadlines for full proposals are March 5, June 5, September 5 and December 5. LOIs are due at least two weeks prior to the proposal deadlines. See full RFP here.

ADDF/NIH RFP: The ADDF will consider financial assistance for relevant NIH grant applications that were scored but not funded in response to certain NIH funding opportunities. Application deadline is rolling. See full RFP here.

Termini IISPV

Cal comunicar abans del 27 d’octubre de 2014 que es vol participar a la convocatòria, enviant un e-mail a . Termini: 20 de novembre de 2014. L’IISPV gestiona les ajudes dels seus investigadors, no és l’entitat convocant

Termini Oficial

05 12 2014

Estàs interessat?

Omple el següent formulari per rebre més informació: